Response to 'Infliximab therapy increases body fat mass in early rheumatoid arthritis independently of changes in disease activity and levels of leptin and adiponectin: a randomized study over 21 months'.
作者信息
Gonzalez-Gay Miguel A, Gonzalez-Juanatey Carlos, Miranda-Filloy Jose A, Martin Javier, Garcia-Unzueta Maria T, Llorca Javier
出版信息
Arthritis Res Ther. 2011 Apr 27;13(2):404. doi: 10.1186/ar3301.
Abstract
摘要
相似文献
1
Response to 'Infliximab therapy increases body fat mass in early rheumatoid arthritis independently of changes in disease activity and levels of leptin and adiponectin: a randomized study over 21 months'.
Arthritis Res Ther. 2011 Apr 27;13(2):404. doi: 10.1186/ar3301.
2
Infliximab therapy increases body fat mass in early rheumatoid arthritis independently of changes in disease activity and levels of leptin and adiponectin: a randomised study over 21 months.
Arthritis Res Ther. 2010;12(5):R197. doi: 10.1186/ar3169. Epub 2010 Oct 21.
3
Effects of a 6-month infliximab treatment on plasma levels of leptin and adiponectin in patients with rheumatoid arthritis.
Fundam Clin Pharmacol. 2009 Oct;23(5):595-600. doi: 10.1111/j.1472-8206.2009.00717.x. Epub 2009 Jun 25.
4
A possible role of leptin-associated increase in soluble interleukin-2 receptor diminishing a clinical response to infliximab in rheumatoid arthritis: Comment on the article by Klaasen et al.
Arthritis Rheum. 2011 Sep;63(9):2833-4; author reply 2834. doi: 10.1002/art.30462.
5
Effect of anti-TNF treatment on body composition and serum adiponectin levels of women with rheumatoid arthritis.
Clin Rheumatol. 2008 Jun;27(6):795-7. doi: 10.1007/s10067-008-0855-7. Epub 2008 Feb 28.
6
Plasma leptin and neuropeptide Y concentrations in patients with rheumatoid arthritis treated with infliximab, a TNF-α antagonist.
Rheumatol Int. 2012 Nov;32(11):3383-9. doi: 10.1007/s00296-011-2182-6. Epub 2011 Nov 3.
7
In early rheumatoid arthritis the combination of methotrexate and infliximab over 2 years reduces the progression of radiological lesions more than methotrexate alone.
Clin Exp Rheumatol. 2005 May-Jun;23(3):289-291.
8
Mycobacterium fortuitum infection complicating infliximab therapy in rheumatoid arthritis.
Clin Exp Rheumatol. 2006 Nov-Dec;24(6):723.
9
Infliximab: a new treatment for rheumatoid arthritis.
Hosp Med. 2001 Mar;62(3):150-2. doi: 10.12968/hosp.2001.62.3.1534.
10
Return of infliximab efficacy after total knee arthroplasty in a patient with rheumatoid arthritis.
Clin Rheumatol. 2008 Apr;27(4):549-50. doi: 10.1007/s10067-008-0858-4. Epub 2008 Feb 26.
引用本文的文献
1
IgG Anti-ghrelin Immune Complexes Are Increased in Rheumatoid Arthritis Patients Under Biologic Therapy and Are Related to Clinical and Metabolic Markers.
Front Endocrinol (Lausanne). 2019 Apr 18;10:252. doi: 10.3389/fendo.2019.00252. eCollection 2019.
2
Anti-TNF-α therapy reduces endothelial cell activation in non-diabetic ankylosing spondylitis patients.
Rheumatol Int. 2015 Dec;35(12):2069-78. doi: 10.1007/s00296-015-3314-1. Epub 2015 Jul 5.
本文引用的文献
1
Infliximab therapy increases body fat mass in early rheumatoid arthritis independently of changes in disease activity and levels of leptin and adiponectin: a randomised study over 21 months.
Arthritis Res Ther. 2010;12(5):R197. doi: 10.1186/ar3169. Epub 2010 Oct 21.
2
Anti-TNF-alpha therapy does not modulate leptin in patients with severe rheumatoid arthritis.
Clin Exp Rheumatol. 2009 Mar-Apr;27(2):222-8.
3
Anti-tumour necrosis factor alpha therapy modulates ghrelin in patients with severe rheumatoid arthritis.
Ann Rheum Dis. 2008 Nov;67(11):1644-6. doi: 10.1136/ard.2008.088773.
4
Metabolic syndrome and subclinical atherosclerosis in rheumatoid arthritis.
J Rheumatol. 2006 Dec;33(12):2425-32. Epub 2006 Oct 15.
5
Influence of anti-TNF-alpha infliximab therapy on adhesion molecules associated with atherogenesis in patients with rheumatoid arthritis.
Clin Exp Rheumatol. 2006 Jul-Aug;24(4):373-9.
6
Anti-tumor necrosis factor-alpha blockade improves insulin resistance in patients with rheumatoid arthritis.
Clin Exp Rheumatol. 2006 Jan-Feb;24(1):83-6.
7
Ghrelin, a novel growth hormone-releasing peptide, in the treatment of cardiopulmonary-associated cachexia.
Intern Med. 2006;45(3):127-34. doi: 10.2169/internalmedicine.45.1402. Epub 2006 Mar 1.
8
Active but transient improvement of endothelial function in rheumatoid arthritis patients undergoing long-term treatment with anti-tumor necrosis factor alpha antibody.
Arthritis Rheum. 2004 Jun 15;51(3):447-50. doi: 10.1002/art.20407.
9
Ghrelin inhibits proinflammatory responses and nuclear factor-kappaB activation in human endothelial cells.
Circulation. 2004 May 11;109(18):2221-6. doi: 10.1161/01.CIR.0000127956.43874.F2. Epub 2004 Apr 26.
10
Weight gain decreases elevated plasma ghrelin concentrations of patients with anorexia nervosa.
Eur J Endocrinol. 2001 Nov;145(5):669-73.
Zotero 插件